Seeking Alpha HealthcareOriginal article
Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety
Phase 3positiveLSD pillPositive
AI Analysis
Summary
Definium's LSD pill achieved its primary endpoint in a late-stage clinical trial for anxiety treatment. The positive trial result drove company stock higher.
Clinical Trial Data
Phase
Phase 3
Primary Endpoint
Met
Outcome Details
achieved primary goal in late-stage trial
Importance:7/10
Sentiment:
0.85
Phase 3 datapositive trial resultsanxietypsychedelicLSD
Read the original article
Published by Seeking Alpha Healthcare on September 14, 2026 3:58 PM